Table 1.
Clinical Characteristics of the Population
| Characteristic | |
|---|---|
| Age (years) | 61.2 ± 8.9 |
| BMI (kg/m2) | 31.4 ± 4.3 |
| Male (%) | 94 |
| Non-Hispanic whites (%) | 66 |
| Diabetes duration (years) | 12 ± 8 |
| Hypertension (%) | 78 |
| Statin use (%) | 60 |
| TZD use (%) | 11 |
| Ever smoker (%) | 72 |
| HbA1c (%) | 9.3 ± 1.4 |
| Total cholesterol/HDL cholesterol | 5.2 ± 1.8 |
| CAC score | 274 (23 – 875) |
| AAC score | 1217 (184 – 4018) |
| CRP (mg/L) | 2.9 (1.3 – 5.7) |
| Lp-PLA2 (ng/mL) | 292 (241 – 351) |
| IL-6 (pg/mL) | 3.1 (2.1 – 4.6) |
Data are presented as mean ± SD, median (25%–75%) or percent (%).
BMI: body mass index; TZD: thiazolidinedione; HbA1c: hemoglobin A1c; HDL: high density lipoprotein; CAC: coronary artery calcium; AAC: abdominal aortic calcium; CRP: high sensitivity C reactive protein; Lp-PLA2: lipoprotein-associated phospholipase A2; IL-6: interleukin-6.